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Abstract
Terminal myogenic differentiation involves an irreversible transition from a proliferative state to a post-mitotic quiescent
state. We showed here that in addition to the previously reported down regulation of G1-related cyclin-associated kinase
activities, this transition was also accompanied by an extensive reorganization of the cyclin^cdk complexes, including a
dramatic shift of cdk2 from cyclin A to cyclin D3. Moreover, the inhibition of cdk activity also correlated with an increase in
the expression of the p27kip1 cdk inhibitor and in its association with the cyclin^cdk2 complexes. Since depletion of p27
substantially reduced the cdk inhibitor activity present in differentiated muscle cells, we believe that the increase in p27
expression along with the reorganization of the cyclin^cdk2 complexes may play an important role in the inhibition of cdk2
activity during the differentiation process. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Terminal di¡erentiation of skeletal muscle cells is
normally accompanied by a permanent and irrevers-
ible withdrawal of the cells from active proliferation
into a postmitotic state that is unresponsive to sub-
sequent mitogenic stimulation [1,2]. Di¡erentiated
cells contain a diploid content of nuclear DNA and
appear to reside in a G0 state. This postmitotic state
has been correlated with the hypophosphorylation of
the retinoblastoma protein RB and a drastic decrease
in both cyclin-dependent kinase 2 (cdk2) and cyclin-
dependent kinase 4 (cdk4) activity [2^5]. The precise
mechanism for the loss of cdk activity has not been
completely de¢ned. A number of studies have impli-
cated the p21cip1 and the p18ink cdk inhibitors, re-
spectively, in the suppression of cdk2 and cdk4 ac-
tivities [3,4,6,7]. However, transgenic knockout mice
de¢cient in p21 expression did not manifest any de-
velopmental abnormality in skeletal muscle forma-
tion [8] suggesting that normal p21 function is dis-
pensable or at least redundant for normal
myogenesis [8]. On the other hand, although an in-
crease in the p27kip1 inhibitor expression during in
vitro myogenesis has been observed [3,6], its involve-
ment in the generation and maintenance of the
growth-arrested state has not been addressed. Simi-
larly, while changes in the expression level of various
G1-related cyclins have been analyzed [5,9,10], how
they might impinge on the postmitotic regulation of
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di¡erentiated muscle cells is not completely under-
stood. Using the skeletal muscle cell line C2C12 as
a model system, we have analyzed cdk2 activity and
the kinase activity associated with three G1-related
cyclins: cyclin A, cyclin E and cyclin D3 [11^16].
We have also monitored the expression level of
cdk2 and these cyclins and their intermolecular asso-
ciations with each other and with the cdk inhibitor
p27kip1 [17]. Our data suggest that in addition to the
well-documented increase in p21cip1, the postmitotic
terminally di¡erentiated state might also involve a
redistribution of cdk2 from cyclin A to cyclin D3
as well as an increased interaction of cyclin D3 and
cdk2 with the p27 cdk inhibitor. The cumulative evi-
dence thus argued that the entry and maintenance of
the postmitotic state requires both the redistribution
of cyclin^cdk complexes and the involvement of mul-
tiple cdk inhibitors.
2. Materials and methods
2.1. Cell culture
C2C12 and 10T1/2 cells were grown in Dulbecco’s
modi¢ed Eagle’s medium (DMEM) containing 10%
fetal bovine serum and 40 Wg/ml gentamycin in a
37‡C humidi¢ed incubator under a 5% CO2 atmos-
phere. The myogenic subclone of 10T1/2 cells (Cl3f)
was derived from the parental 10T1/2 cells by stable
transfection of the MyoD containing expression plas-
mid pEMC11 [18] and isolated by G418 selection.
Di¡erentiation of the myogenic cells was initiated
by exposing cells at about 50% con£uence to
DMEM containing 5% horse serum. Under such
conditions, morphological and biochemical di¡eren-
tiation generally became detectable after 2 days in
the di¡erentiation-permissive medium with more
than 50% of the cells undergoing di¡erentiation by
day 4 [19,20]. Unless otherwise stated, the di¡erenti-
ated cell extracts used in the studies were harvested
on day 4 after the medium switch.
2.2. Immunoprecipitation and immunoblot
The antibodies used for the study include: anti-
cyclin A antibody H-432, anti-cyclin D1 antibody
73-13G, anti-cyclin D3 antibody C-16, anti-cyclin E
antibody M-20, anti-cdk2 antibody M-2, and anti-
p27 antibody C-19 (purchased from Santa Cruz).
For immunoprecipitation, cells were lysed in lysis
bu¡er (50 mM Tris, pH 8.0, 120 mM NaCl, 1 mM
EDTA, containing 0.5% NP40, 2 Wg/ml aprotinin,
0.2 mM PMSF, 2 WM leupeptin and 1 WM pepstatin)
for 15 min on ice. Nuclei were removed by centrifug-
ing the cell lysate at 11 000 rpm for 5 min. The lysate
was incubated with various primary antibodies for
1 h on ice. Ten Wl of 50% protein A agarose (Boehr-
inger Mannheim) was then added to each sample
tube and the incubation was continued at 4‡C for 1 h
with rocking, followed by centrifugation to isolate
the immunocomplexes. For immunoblot analysis,
cell lysates or immunoprecipitates were separated
by SDS^PAGE and transferred to nitrocellulose
membrane using a Bio-Rad mini-blot electrotransfer
apparatus in transfer bu¡er containing 25 mM Tris,
192 mM glycine, 0.075% SDS and 20% methanol.
The membrane was incubated in Western wash bu¡-
er (20 mM Tris, 150 mM NaCl, 0.05% Tween) con-
taining 2% milk to block non-speci¢c binding, fol-
lowed by incubation with primary antibodies diluted
in Western wash bu¡er containing 2% milk at the
appropriate dilution for each antibody. The mem-
brane was wash extensively with Western wash bu¡er
and then incubated with horseradish peroxidase-con-
jugated antibody (Bio-Rad, 1:2000~4000 dilution)
and detected by enhanced chemiluminescence system
(Amersham, Dupont and Pierce).
2.3. Cdk2 kinase activity assay
Cdk2 kinase assay was performed on immunocom-
plexes from cell lysates as described by Guo et al.
with slight modi¢cations [4]. Brie£y, the protein A
agarose beads containing the immunocomplexes were
washed three times with 500 Wl of lysis bu¡er and
twice with 500 Wl kinase bu¡er (50 mM Tris, pH 8.0,
10 mM MgCl2, 1 mM DTT). Fifty microliters of
kinase bu¡er containing 0.05 mg/ml histone, 10
mM ATP and 10 WCi Q-32P-ATP was added to the
agarose beads. After incubation at room temperature
for 20 min, the reaction was terminated by adding 50
Wl of 2Usample bu¡er. Samples were separated by
SDS^gel and the dried gel was exposed to X-ray ¢lm.
For experiments involving the inhibition of cdk2 ac-
tivity by heat-released factor(s), total cell lysates or
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immunocomplexes resuspended in lysis bu¡er were
boiled for 4 min and then centrifuged at 10 000
rpm for 5 min at 4‡C. The supernatants from the
centrifugation step were added to proliferating cell
lysates and incubated for 30 min on ice. Cdk2 activ-
ity was then assayed following immunoprecipitation
by anti-cdk2 antibody.
2.4. Immunodepletion of p27
Immunoprecipitation was performed as described
above using either 5 Wl of anti-p27 antibody (0.1
mg/ml) or normal rabbit IgG. The supernatant sep-
arated from the protein A agarose beads by centri-
fugation were immunoprecipitated with the same
amount of antibody two more times. Each immuno-
precipitate was analyzed by SDS^PAGE and immu-
noblot with anti-p27 antibody to check for the de-
gree of p27 depletion. The ¢nal supernatant was used
for inhibition of cdk2 activity as described above.
3. Results
3.1. A low level of cyclin D3 associated kinase activity
is present in proliferating myoblasts, but not in
di¡erentiated muscle cells
Previous studies have shown that terminally di¡er-
entiated muscle cells expressed little or no cdk2 or
cdk4 activity [2^5]. Using antibodies directed against
cdk2 and a number of G1-related cyclins to precip-
itate kinase activity from C2C12 skeletal muscle cells,
we have con¢rmed that di¡erentiation was correlated
with a decrease in immunoprecipitable cdk2 activity
and kinase activities associated with cyclin E and
cyclin A (Fig. 1). Interestingly, we also detected a
low cyclin D3-associated kinase activity in proliferat-
ing cells, which showed a further decline following
muscle cell di¡erentiation. This D3-associated kinase
activity is most likely contributed by D3^cdk2 com-
plexes, since previous studies have shown that cdk4
does not phosphorylate histone e⁄ciently in vitro
[21,22]. Consistent with this idea, we could not detect
histone kinase activity in our anti-cdk4 immunopre-
cipitates and no cyclin D1-associated histone kinase
was detected in either proliferating or di¡erentiated
cells (data not shown).
3.2. The decrease in cyclin D3 associated kinase
activity was accompanied by a paradoxical but
muscle-di¡erentiation-speci¢c increase in cyclin
D3 expression
Previous studies have shown that muscle di¡eren-
tiation in several in vitro systems was accompanied
by changes in the expression levels of various cyclins,
including a paradoxical increase of cyclin D3 [5,9].
Results from our study con¢rmed small decreases in
the levels of cyclin E, cyclin A and cdk2, a relatively
large decrease in the level of cyclin D1 and an
equally striking increase in cyclin D3 in di¡erentiated
C2C12 cells (Fig. 2A).
In addition, we have extended the observation to
demonstrate that the increase in cyclin D3 was spe-
ci¢c to the myogenic di¡erentiation process. A myo-
genic subclone (Cl3F) of the ¢broblastic 10T1/2 em-
bryonic cell line was generated by stable transfection
of a MyoD1 expressing vector and the cyclin D3
levels of Cl3f cells and the parental 10T1/2 cells
were examined following exposure to di¡erentia-
tion-inducing conditions. Whereas the parental
10T1/2 cells which could not di¡erentiate did not
exhibit any increase in cyclin D3 level, the Cl3f cells
exhibited a pronounced increase in cyclin D3 when
Fig. 1. Di¡erentiated C2C12 cells contained decreased levels of
cdk2 activity and histone kinase activity associated with various
G1 cyclins. Cell extracts from proliferating (P) and di¡erenti-
ated (D) C2C12 cells were subjected to immunocomplex kinase
assays using histone as substrate following immunoprecipitation
with anti-cdk2 antibody (cdk2 ip), anti-cyclin D3 antibody (cyc
D3 ip), anti-cyclin E antibody (cyc E ip) or anti-cyclin A anti-
body (cyc A ip) as described in Section 2. The samples were
then analyzed by SDS^PAGE and autoradiography. The arrow
indicates where the phosphorylated histone migrates on the gel.
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‘induced’ to di¡erentiate (Fig. 2B). Mock transfected
10T1/2 clones or 10T1/2 clones transfected with un-
related plasmids also did not exhibit any increase in
cyclin D3 levels (data not shown). The increase in
cyclin D3 protein thus appears to be an intrinsic
part of the di¡erentiation program that can be acti-
vated by the ectopic overexpression of a single myo-
genic regulatory gene.
3.3. The increase in cyclin D3 expression was
accompanied by its increased association with
cdk2
We examined next whether the association be-
tween the various cyclins and cyclin-dependent ki-
nases might be altered during the di¡erentiation pro-
cess. We showed that antibody to cyclin E
precipitated similar amounts of cdk2 from both pro-
liferating and di¡erentiated cells (Fig. 3A) while the
amount of cyclin D3 co-precipitating with cdk2 in-
creased following cell di¡erentiation (Fig. 3B). This
increase in interaction between cyclin D3 and cdk2
was again speci¢c to the muscle di¡erentiation pro-
cess since increased association was only observed
with the myogenic subclone Cl3f following di¡eren-
tiation and not with parental 10T1/2 cells subjected
to similar culture conditions (Fig. 3C, lanes 3^7). In
contrast, cdk2 was detected in co-immunoprecipi-
tates with antibody to cyclin A from proliferating
cells, but not from di¡erentiated cells (Fig. 3D) and
little to no cyclin D1 was detected in anti-cdk2 im-
munoprecipitates from either the proliferating or dif-
ferentiated muscle cells (Fig. 3E).
3.4. Expression of the heat-stable cdk inhibitor p27kip1
increased in the di¡erentiated cells and became
associated with speci¢c cyclin and cdk complexes
The p21 family of cdk inhibitors: p21cip1, p27kip1
and p57kip2 had been shown to bind and inhibit both
cdk2 and cdk4 activities in vitro [23,24]. Although
p27 is highly expressed in di¡erentiated muscle cells
[6], its potential involvement in muscle di¡erentiation
has largely been overlooked, in part because p27 ex-
pression also increased as cells became quiescent
[17,25]. We found that the level of p27 was indeed
Fig. 2. Expression levels of cdk2 and various G1 cyclins in C2C12 and other myogenic and non-myogenic cell lines. Total cell extracts
normalized to contain equal amounts of proteins were electrophoresed on SDS^PAGE, transferred to nitrocellulose and probed with
speci¢c antibodies against cdk2 and the indicated cyclins, followed by immunodetection with enhanced chemiluminescence as described
in Section 2. The arrows mark the expected positions of either cdk2 or the particular cyclin indicated on top of each gel as deter-
mined by comparison with molecular size markers. Panel A demonstrates that muscle di¡erentiation was accompanied by di¡erential
changes in the level of expression of cdk2 and various G1 cyclins. Lane P, extracts from proliferating cells. Lane D, extracts from dif-
ferentiated cells. In panel B, cyclin D3 expression was examined in cultures of the non-myogenic 10T1/2 cells or a myogenic subclone
of these cells (Cl3f). When subjected to the di¡erentiation-inducing conditions, the Cl3f cells undergo myogenic di¡erentiation (D)
while the 10T1/2 cells became quiescent (Q) but were unable to di¡erentiate.
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low in subcon£uent proliferating C2C12 cells, and
increased rapidly as the cultures were exposed to
‘di¡erentiation-inducing’ conditions (Fig. 4A). The
expression was maintained at a raised level following
di¡erentiation, which typically began after 2 days in
the di¡erentiation medium.
We examined next the association of p27 with var-
ious cyclins and cdks. Lysates from proliferating and
di¡erentiated C2C12 cells were immunoprecipitated
with antibodies directed against speci¢c cyclins and
cdks and the presence of p27 in the immunoprecipi-
tate was analyzed by immunoblotting with anti-p27
antibody. While some p27^cyclin D3 complexes were
detectable in the proliferating cell lysates, the amount
of p27 protein associated with cyclin D3 increased
substantially following di¡erentiation (Fig. 5A). Sim-
Fig. 3. Co-immunoprecipitation of various cyclins with cdk2 in C2C12 and other myogenic and non-myogenic cell lines. Total cell ly-
sates were subjected to immunoprecipitation with either anti-cdk2 or anti- cyclin antibody. The immunoprecipitates were then ana-
lyzed by immunoblotting with the complementary antibody to look for co-precipitation between cdk2 and the speci¢c cyclin. For
comparison, an aliquot of the total lysate (15% of the amount used in the immunoprecipitation) was electrophoresed directly and ana-
lyzed by immunoblot (Lanes 3 and 4 in panels A, D, and E; lanes 1 and 2 in panel B). Except for panel C, the amount of lysates
from proliferating (P) and di¡erentiated (D) cultures were adjusted to contain the same amount of the antigenic protein being precipi-
tated (cyclin E for panel A, cdk2 for panels B and E, and cyclin A for panel D). (A) Anti-cyclin E antibody precipitated cdk2 from
both proliferating and di¡erentiated C2C12 cells. (B) Anti-cdk2 antibody precipitated more cyclin D3 from di¡erentiated C2C12 cells.
(C) Anti-cdk2 antibody precipitated increased amounts of cyclin D3 only in di¡erentiation-competent cells. Lysates from C2C12, and
the non-myogenic 10T1/2 and myogenic Cl3f were normalized to contain the same amount of cyclin D3 prior to immunoprecipitation
with the anti-cdk2 antibody. Lane H represents immunoprecipitates from 10T1/2 cells that were exposed to culture condition used to
induce di¡erentiation in the other cell types. Lane Q represents 10T1/2 cells that had become quiescent and were no longer proliferat-
ing. (D) cdk2 was precipitated by anti-cyclin A antibody from proliferating C2C12 cell lysates, but not from di¡erentiated C2C12 cell
lysates. (E) Anti-cdk2 antibody did not precipitate cyclin D1 either in proliferating or di¡erentiated C2C12 cells.
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ilarly, binding between cdk2 and p27 was virtually
undetectable in the proliferating cells, but became
clearly evident following di¡erentiation. Likewise,
p27 protein could be co-precipitated with the anti-
cyclin E antibody only following cellular di¡erentia-
tion. In contrast, no p27 could be detected in the
cyclin A immunoprecipitates from either the prolif-
erating or di¡erentiated cell lysates (Fig. 5B).
3.5. Di¡erentiated muscle cell lysates contained a cdk
inhibitory activity that could be depleted by
immunoprecipitation with anti-p27 antibodies
Previous studies have shown that the cdk-inhibi-
tory activity of p27kip1 is heat stable and can be freed
from associated proteins upon heat denaturation
[4,17,25]. We showed that di¡erentiated C2C12 cell
lysates heated to 100‡C indeed released p27kip1 (Fig.
4B) and a cdk-inhibitor activity that could block the
kinase activity of cdk2 from proliferating cells (Fig.
4C).
To assess the nature of the cdk2 inhibitory activity
further, we incubated di¡erentiated cell lysates sepa-
rately with either anti-cyclin D3 or anti-p27 antibod-
ies and protein A agarose beads, and heat-denatured
the immunoprecipitates to see if inhibitory activity
would be released from the immune complexes.
Our results demonstrated a substantial amount of
cdk2 inhibitory activity could be recovered from
these complexes (Fig. 4D, lanes 2 and 3), whereas
no inhibitory activity was recovered when non-im-
mune IgG was used (Fig. 4D, lane 4). It thus ap-
Fig. 4. Expression of p27 and cdk2 inhibitory activity in C2C12 cells. (A) Expression of p27 protein increased with increasing time in
di¡erentiation-inducing conditions. Total lysates from C2C12 cells exposed to di¡erentiation-inducing conditions for the indicated
lengths of time were analyzed by immunoblotting with anti-p27 antibody. (B) Release of p27 protein from both proliferating and dif-
ferentiated C2C12 cells into the supernatant by boiling. Total lysates (lanes 1 and 2) or supernatant from lysates that have been boiled
(lanes 3 and 4) were analyzed by immunoblotting with the anti-p27 antibody. Lane P, lysates from proliferating cells. Lane D, lysates
from di¡erentiated cells. (C) Boiling released a cdk2 inhibitory activity from di¡erentiated cell extract. Extracts from proliferating
C2C12 cells were analyzed for cdk2 activity by the immunocomplex kinase assay described in Section 2 (lane 1), or preincubated with
boiled and clari¢ed lysate from di¡erentiated cells before immunoprecipitation with the anti-cdk2 antibody (lane 2). (D) the inhibitory
activity can be immunoprecipitated by anti-p27 and anti-cyclin D3 antibody. Total lysates from di¡erentiated C2C12 cells were incu-
bated with anti-p27 (lane 2), anti-cyclin D3 antibody (lane 3) or non-immune IgG (lane 4) followed by protein A agarose. Materials
released from the agarose beads after boiling were assayed for cdk2 inhibitory activity as described for panel C. Lane 1 represents the
cdk2 activity precipitated by anti-cdk2 antibody from proliferating cell lysate with no cdk inhibitors added.
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peared that at least part of the inhibitory activity in
the di¡erentiated cells corresponds to the p27 protein
and is associated with cyclin D3 in di¡erentiated
muscle cells.
To determine what extent of the inhibitory activity
observed was attributable to p27, we depleted p27 by
repetitive immunoprecipitation with anti-p27 anti-
body and examined the lysates for residual cdk-in-
hibitory activity. As shown in Fig. 6A, the anti-p27
precipitates contained very little p27 protein by the
third round of immunoprecipitation indicating that
the p27 protein had been depleted from the lysates.
Coincident with this loss of p27 immunoreactivity,
the level of cdk2 inhibitory activity that could be
released from the cell lysate upon heating was also
dramatically reduced (Fig. 6B, lane 4). The reduction
of cdk2 inhibitory activity was not due to non-spe-
ci¢c absorption of the cdk2 inhibitor(s) to the aga-
rose beads used in the immunoprecipitation, since
lysates subjected to the same precipitation protocol
using non-immune IgG retained full inhibitory activ-
ity (Fig. 6B, lane 3).
4. Discussion
Using the murine myogenic C2C12 cells as our
model system, we have investigated the molecular
mechanisms involved in regulating cell cycle with-
drawal in di¡erentiating skeletal muscle cells. Our
results con¢rmed that cdk2 kinase activity was dras-
tically diminished upon muscle di¡erentiation [3,4]
and that the di¡erentiation process was accompanied
by changes in the expression levels of multiple com-
ponents of the cell cycle regulatory machinery, in-
cluding the down regulation of cdk2, cyclin A, cyclin
D1 and cyclin E, and the upregulation of cyclin D3
and p27kip1. While the exact magnitudes of the
changes in some of the individual components may
di¡er slightly with those reported in some studies, the
general pattern we observed is consistent with pre-
vious ¢ndings (reviewed in Walsh and Perlman [26]).
In addition to con¢rming these ¢ndings, our study
has extended the previous observations by demon-
strating that a drastic reorganization of the cyclin^
cdk complexes also takes place during skeletal
muscle di¡erentiation (summarized schematically in
Fig. 7). The most notable aspect of this reorganiza-
tion is the striking decrease in cdk2 binding to cyclin
A and a corresponding increase in binding to cyclin
D3. In contrast, the cyclin E^cdk2 complex remained
intact, but appeared to have become increasingly as-
sociated with the cdk inhibitor p27kip1. We corrobo-
rated these physical ¢ndings by showing that both
Fig. 5. Association of p27 with cdk2 and various cyclins. Total cell lysates from proliferating (P) and di¡erentiated (D) cultures were
subjected to immunoprecipitation with the speci¢c anti-cdk2 or anti-cyclin antibody indicated. The immunoprecipitates were then ana-
lyzed by immunoblotting with anti-p27 antibody. For comparison, an aliquot of total lysates (15% of the amount used in the immu-
noprecipitation) was electrophoresed directly and analyzed by immunoblot (lysate lanes). Each pair of lysates was adjusted so as to
contain approximately the same amount of cyclin or cdk2 targeted by the immunoprecipitating antibody. (A) p27 associated with cy-
clin D3 in lysates from both proliferating and di¡erentiated cultures, but only with cdk2 in the di¡erentiated cultures. Note that be-
cause of the large increase in cyclin D3 expression during di¡erentiation, a much larger amount of proliferating cell extract was used
in the immunoprecipitation, leading to the apparent reduction of p27 level in the di¡erentiated cell lysate. (B) p27 associated with cy-
clin E in di¡erentiated culture lysates, but not with cyclin A, in either proliferating or di¡erentiated cultures.
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cyclin A- and cyclin E-associated kinase activities
were greatly reduced. Our data thus demonstrated
that although myogenic di¡erentiation was accompa-
nied by the coordinate extinguishing of cdk activities
from two cyclin^cdk complexes that are both impor-
tant for entry into S phase [13,14,27], the decrease in
kinase activity is accomplished by di¡erent molecular
mechanisms: decreased binding to cdk2 in the case
of cyclin A and increased binding of cdk inhibitors in
the case of cyclin E.
While the paradoxical increase in cyclin D3 expres-
sion during muscle di¡erentiation has been reported
previously [5,9,28], its increased association with
cdk2 and with the cdk inhibitor p27kip1 has never
been documented. In this regard, although interac-
tions between cyclin D3 and cdk2 could occur in
vitro and D3^cdk2 complexes have been detected in
some cells [29,30], it is widely believed that cyclin D3
exerts its regulatory e¡ects primarily through cdk4.
However, since results from the current study clearly
demonstrated that both the increase in cyclin D3
expression and its increased interaction with cdk2
were highly speci¢c to the muscle di¡erentiation pro-
cess, the possibility that the D3^cdk2 interaction may
have important biological relevance can no longer be
ignored (see further discussion below).
Another novel ¢nding in this study is the involve-
ment of p27 in regulating cdk2 activity in di¡erenti-
ated skeletal muscle cells. Previous studies have im-
plicated increased expressions of other cdk
inhibitors, including p18ink4c [3] and p21cip1 [4,6,7]
respectively, in the inhibition of cdk4 and cdk2 ac-
tivities during skeletal muscle di¡erentiation. In ad-
dition, the involvement p57kip2 is suggested by p57
genetic ‘knockout’ mice [31,32] and by the recent
report that mice with combined de¢ciencies in p57
and p21 exhibit a dramatic defect in skeletal muscle
development [33]. On the other hand, our immuno-
depletion experiment clearly indicated that a signi¢-
cant portion of the heat-stable cdk2 inhibitory activ-
ity present in di¡erentiated muscle cells was
contributed by p27kip1 since the anti-p27 antibody
Fig. 6. Immunodepletion of p27 removes the cdk2 inhibitory activity from di¡erentiated C2C12 lysates. Total lysates form di¡erenti-
ated C2C12 cultures were subjected to three rounds of immunoprecipitation with anti-p27 antibody or with non-immune IgG. In pan-
el A, the immunoprecipitates were analyzed by immunoblot with anti-p27 antibody. Lanes 1, 2 and 3 correspond to anti-p27 immuno-
precipitates from the ¢rst, second and third round of precipitation. The precipitates from the ¢rst round of precipitation using the
non-immune IgG are shown in lane 4. In panel B, the supernatant after the third round of precipitation was boiled and the released
material was assayed for inhibitory activity as described in Fig. 4. Lane 1 corresponds to control cdk2 activity precipitated directly
from untreated proliferating cell lysate; lane 2 corresponds to cdk2 activity from a sample that had been preincubated with undepleted
boiled lysate from di¡erentiated cells ; lane 3 represents cdk2 activity from sample preincubated with non-immune IgG ‘depleted’ ly-
sate; lane 4 represents cdk2 activity from sample preincubated with anti-p27 depleted lysate.
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is speci¢c for p27 and did not cross-react with p21cip1
in muscle cell lysates (see Figs. 4^6). Our ¢nding of
p27 involvement in muscle development is consistent
with the high level of p27 expression in skeletal
muscle tissues [24] and with studies demonstrating
that mice de¢cient in p27 expression grew to a bigger
size than normal [34^36]. This conclusion is further
validated by a recent report, which appeared after
the completion of our study and which demonstrated
that p27 is upregulated transiently during myogenic
di¡erentiation in vivo [37]. Since the increase in p27
expression occurred rapidly prior to the overt expres-
sion of di¡erentiated functions, we believe that its
increase may contribute to the initial withdrawal
from the cell cycle that allows muscle di¡erentiation
to proceed. The other cdk inhibitors may then func-
tion in the di¡erentiated cells to maintain the perma-
nent postmitotic state.
Among the most interesting questions raised by
the current study are the unexpected and apparently
coordinated upregulation of cyclin D3 and p27kip1,
and their increased association with cdk2 (illustrated
in Fig. 7). What role may this reorganization of cdk2
complexes play in the myogenic di¡erentiation pro-
cess? One possibility is that the simultaneous in-
crease in cyclin D3 and p27 expression may serve
to sequester cdk2 from cyclin A by favoring the for-
mation of D3^cdk2^p27 complexes (see Fig. 7), since
cyclin D3 interacts more strongly with p27 relative to
cyclin A [24], and the ternary cyclin^cdk2^p27 com-
plexes are more stable than the binary cyclin^cdk2
complexes [38,39]. Such a reorganization of cyclin^
cdk2 complexes may be responsible for the elimina-
tion of the cyclin A-mediated cdk2 activity. Another
intriguing possibility is that the binding to D3 and
p27 may redirect cdk2 to other potential target sub-
strates. In this regard, the existence of active cyclin^
cdk complexes that contain associated cdk inhibitors
is well documented [39,40] and a recent report has
demonstrated the p27 protein could indeed modulate
the substrate speci¢city of its associated cyclin^cdk
complexes [41]. It is also interesting to note that cy-
clin D^cdk2 complexes exhibit in vitro substrate spe-
ci¢city that is distinct from either cyclin E^cdk2 or
cyclin D^cdk4 [42]. Thus, it is not too surprising that
the cyclin D3^cdk2^p27 complex in di¡erentiated
muscle cells (see Fig. 7) might retain residual activity
towards speci¢c substrates with functions unrelated
to cell cycle progression. In partial support of this
idea is the ¢nding that overexpression of cyclin D1,
Fig. 7. Model depicting how the decline of cdk2 activity might be regulated by increased p27 and cyclin D3 expression and the reor-
ganization of the cdk2’cyclin complexes. Findings from these studies documented an increase in cyclin D3 and p27 expression and in-
teraction during muscle di¡erentiation. This is postulated to result in the sequestration of cdk2 from cyclin A into inactive D3^p27^
cdk2 complexes. The cyclin E-associated cdk2 activity was also blocked by interaction with p27, resulting in the virtually complete in-
hibition of cdk2. Additional interactions between cdk2 and p21 also contribute to the inhibition of cdk2 [4,6], but the exact composi-
tion of the p21^cdk2 complexes has yet to be de¢ned.
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but not cyclin D3, e⁄ciently inhibits myogenic di¡er-
entiation and muscle-speci¢c gene expression [43,44].
In summary, while the precise roles of cyclin D3
and p27 in the muscle di¡erentiation process still
need to be elucidated, it is becoming clear that the
inhibition of cell proliferation accompanying termi-
nal myogenic di¡erentiation is orchestrated by the
coordinated actions of multiple cdk inhibitors and
that the concomitant reorganization of the existing
cyclin^cdk complexes may also be critically impor-
tant.
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